Navigation Links
Janssen Launches EXPLORER, Global Cardiovascular Research Program, Beginning with Five New Studies in Patients with Unmet Medical Needs
Date:3/8/2013

marketing rights for XARELTO®, and is supported by the Bayer HealthCare U.S. sales force.

For more information about XARELTO®, visit www.xarelto-us.com. The XARELTO® CarePath™ Support Program is a resource designed for health care providers, patients and caregivers. Visit www.xareltocarepath.com or call 1-888-XARELTO to learn more about the XARELTO® CarePath™ resources focused on access, education and adherence.

Important Safety Information

WHAT IS THE MOST IMPORTANT INFORMATION I SHOULD KNOW ABOUT XARELTO®?

  • For people taking XARELTO® for atrial fibrillation:
    People with atrial fibrillation (an irregular heart beat) are at an increased risk of forming a blood clot in the heart, which can travel to the brain, causing a stroke, or to other parts of the body. XARELTO® lowers your chance of having a stroke by helping to prevent clots from forming. If you stop taking XARELTO®, you may have increased risk of forming a clot in your blood.
    Do not stop taking XARELTO® without talking to the doctor who prescribes it for you. Stopping XARELTO® increases your risk of having a stroke.
    If you have to stop taking XARELTO®, your doctor may prescribe another blood thinner medicine to prevent a blood clot from forming.
  • XARELTO® can cause bleeding, which can be serious, and rarely may lead to death. This is because XARELTO® is a blood thinner medicine that reduces blood clotting. While you take XARELTO® you are likely to bruise more easily and it may take longer for bleeding to stop

You may have a higher risk of bleeding if you take XARELTO<
'/>"/>

SOURCE Janssen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism
2. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin to Treat Patients with Type 2 Diabetes
3. Janssen Announces Initiation Of Phase 3 Development Program For Sirukumab In Rheumatoid Arthritis
4. Janssen Biotech Announces Global License and Development Agreement for Investigational Anti-Cancer Agent Daratumumab
5. West Announces Agreement with Janssen Biotech to Develop and Commercialize a New Self-injection Technology
6. Janssen Announces Collaboration with Vertex on Phase 2 Study to Investigate an All-Oral Regimen of Simeprevir (TMC435) and VX-135 for Treatment of Hepatitis C
7. Janssen and Johnson & Johnson to Provide Webcast Presentation of Immunology Pivotal Phase 3 Data Being Presented at the American College of Rheumatology Annual Meeting
8. Efficacy and Safety Data from Phase 2B Trials of Janssens Simeprevir in Hepatitis C Patients with Advanced Fibrosis of the Liver Presented at Annual Meeting of the American Association for the Study of Liver Diseases
9. Janssen Research & Development Announces Establishment of Global Cross-Pharmaceutical Clinical Trial Investigator Databank
10. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin/Metformin Fixed-Dose Combination Therapy to Treat Patients with Type 2 Diabetes
11. Janssen Labs at San Diego Expands to Add Concept Lab and Open Collaboration Space to Accommodate Individual Entrepreneurs and Additional Life Science Start-Ups
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... , Nov. 25, 2014  Unilife Corporation (NASDAQ: ... injectable drug delivery systems, today announced that its Chairman ... present at the Piper Jaffray 26th Annual Healthcare Conference ... EST on Tuesday, December 2, 2014. ... as a "live" listen only Webcast. To listen, please ...
(Date:11/26/2014)... Fla. , Nov. 25, 2014  Breckenridge ... into a multi-product ANDA agreement with Pii (Pharmaceutics ... ) under which Breckenridge and Pii expect to ... terms of the agreement, Pii will develop, manufacture ... and distribute the products under its own label.  ...
(Date:11/26/2014)... Pharmaceuticals plc (Nasdaq: JAZZ ) today announced that the ... conferences.  , 31 st NASDAQ Investor Program ... 2014 at 6:45 a.m. EST / 11:45 a.m. GMT. Iain ... provide an overview of the company and a business and financial ... in New York, NY on Tuesday, December ...
Breaking Medicine Technology:Unilife to Present at the Piper Jaffray 26th Annual Healthcare Conference on December 2nd 2Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with Pharmaceutics International, Inc. 2Jazz Pharmaceuticals Announces Participation in Two Investor Conferences 2
... of Victor, NY , announced today that the Company has ... the Qualifying Therapeutic Discovery Project (QTDP), which was created by ... Act of 2010. In July, PharmaNova applied for project grants ... nanoparticulate products. NovaSperse(SM) is a unique ...
... Nov. 8, 2010 Parascript, LLC, the image analysis ... was awarded a cash grant of $244,479.25 under the ... therapeutic discovery project program targets projects that show significant ... reduce the long-term growth of health care costs or ...
Cached Medicine Technology:NovaSperse(SM) Nanoparticle Innovator, PharmaNova, Inc., Awarded Four Government Grants Toward Development of New Therapeutic Products Under Congressional Qualifying Therapeutic Discovery Project Initiative 2Parascript Awarded $244,479.25 Affordable Care Act Grant From the U.S. Government 2
(Date:11/27/2014)... November 27, 2014 Allowing children to help ... during school, helps give children responsibility, ownership, boosts self-esteem, and ... , Now, the real question is, how do you ... secret? According to a study published by Child Development Journal, ... a dramatic effect on a child’s willingness to lend a ...
(Date:11/27/2014)... 27, 2014 RBSEO Services, a ... engine optimization service just at $99. RBSEO Services ... cannot afford costly search engine optimization service. So, ... their affordablity and requirements into consideration. , ... it has not compromised with the service quality. ...
(Date:11/27/2014)... November 27, 2014 Ethane Web Technologies, an ... will provide a 10% Christmas discount on PPC service. The ... The discount offer will begin on 1 December 2014 and ... About this offer, a PPC professional working at Ethane Web ... for small businesses, as this big discount would make the ...
(Date:11/27/2014)... Denver,CO (PRWEB) November 27, 2014 In ... photos, bring an important gift home this holiday season ... and Alzheimer’s disease. Visiting with relatives over the holidays ... of family members. Although some change in cognitive ability ... a part of normal aging. Recognizing the difference between ...
(Date:11/26/2014)... Healthpointe is proud to provide Occupational Medicine ... it will be led by a renowned specialist. Dr. ... Occupational Medicine and utilizes the latest medical technology to ... care for employers and their employees, and aims his ... an Occupational Medicine physician, Dr. Martin Del ...
Breaking Medicine News(10 mins):Health News:RBSEO Services Announces SEO Services at $99 Only 2Health News:Ethane Web Technologies Announces 10% Christmas Discount on PPC Service 2Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 2Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 3Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 4Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 5Health News:Healthpointe now offering Occupational Medicine in their Perris Medical Clinic 2Health News:Healthpointe now offering Occupational Medicine in their Perris Medical Clinic 3
... type 1 a rare disease in which tumors grow ... by crosstalk between cells in the nerves and cells in ... National Institutes of Health (NIH) and the Department of Defense ... treating certain kinds of blood cancer curbs tumor growth in ...
... One errant cough or unexpected,sneeze and the workplace ... As the flu season approaches, HR managers prepare to,deal ... estimates that the cost of influenza to the U.S. ... can range from $71 billion,to $167 billion a year., ...
... Living,Inc. (NYSE: SRZ ) today announced that it ... 7, 2008, at 9:00 a.m. ET to discuss the,financial ... executive,officer (effective November 1, 2008), Richard Nadeau, chief financial,officer, ... call., The call-in number for the conference call ...
... Institute of Health and Nutrition, Latino Nutrition Coalition are ... ... Inc. (GMI), today,announced the launch of a unique, three-year, grassroots program ... nutritious food as part of their daily routine. Called Mente,Sana en ...
... Action Network, American,Heart Association, American Lung Association, American ... Oct. 30 Demonstrating again that,it is not ... Philip Morris,is launching an aggressive new campaign to ... campaign is built around a new look for ...
... LLC formally launched a,refreshed website ( ... and,potential customers on October 28, 2008. The ... target-market, including temporary,nurse staffing agencies, medical transcription ... healthcare vendors., Some of the site,s ...
Cached Medicine News:Health News:Researchers identify mechanism, possible drug treatment for tumors in neurofibromatosis 2Health News:Researchers identify mechanism, possible drug treatment for tumors in neurofibromatosis 3Health News:Going 'Green' May Mean Fewer Colds This Season 2Health News:Going 'Green' May Mean Fewer Colds This Season 3Health News:Sunrise to Host Conference Call and Webcast to Discuss the Company's Financial Results for the Third Quarter 2008 2Health News:General Mills, Inc. Launches One-Of-A-Kind Grassroots Health and Nutrition Initiative Designed to Help Hispanic Families Eat Better 2Health News:General Mills, Inc. Launches One-Of-A-Kind Grassroots Health and Nutrition Initiative Designed to Help Hispanic Families Eat Better 3Health News:Deadly in Pink: Philip Morris' New Look for Virginia Slims Cigarettes Shows Contempt for Women's Health 2Health News:Deadly in Pink: Philip Morris' New Look for Virginia Slims Cigarettes Shows Contempt for Women's Health 3Health News:PRN Funding Refreshes Website Experience 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: